Patents by Inventor Tianwen SUN

Tianwen SUN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240226107
    Abstract: The present application discloses a compound of formula (I) as a USP1 inhibitor, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition comprising the compound or the pharmaceutically acceptable salt thereof, and use thereof in prevention or treatment of diseases associated with USP1.
    Type: Application
    Filed: April 8, 2022
    Publication date: July 11, 2024
    Inventors: Wei ZHU, Hao ZOU, Wansun MAI, Dongxing ZHU, Xiang CHEN, Tao WANG, Tianwen SUN, Zhengtao LI
  • Publication number: 20230002355
    Abstract: The present invention falls within the field of medical chemistry and relates to a class of compounds as SHP2 inhibitors and the use thereof. Specifically, the present invention provides a compound represented by formula (I), or an isomer, a pharmaceutically acceptable salt, a solvate, a crystal or a prodrug thereof, a preparation method therefor, a pharmaceutical composition comprising the compounds, and the use of the compounds or the composition for treating a disease mediated by SHP2.
    Type: Application
    Filed: November 6, 2020
    Publication date: January 5, 2023
    Applicant: NANJING SANHOME PHARMACEUTICAL CO., LTD.
    Inventors: Liwen ZHAO, Xiaowei WANG, Xu QUAN, Zhishuai YANG, Yazhou WANG, Tao XU, Mingxiao WANG, Cheng LIANG, Jing GUO, Zhichao TANG, Chunmeng WANG, Haizhou LUO, Xue LI, Zheng XU, Tianwen SUN
  • Patent number: 10434098
    Abstract: Provided are a deuterium-substituted dehydrophenylahistin-like compound, preparation method thereof and use in a preparation of antitumor drugs. The deuterium-substituted dehydrophenylahistin-like compound has a structure of general formula (I), and a synthesis method thereof comprises: firstly conducting a condensation reaction of diacetyldiketopiperazine and an aldehyde intermediate a or a deuterated aldehyde compound b to form a heterocyclic compound c or a deuterium-containing heterocyclic compound d, which is then subjected to a condensation reaction with benzaldehyde and a deuterium-substituted benzaldehyde-like compound to form the deuterium-substituted dehydrophenylahistin-like compound. Also provided are a highly effective deuterated aldehyde intermediate with a high deuterium substitution rate and a deuterium-containing heterocycle intermediate, and a synthesis method thereof.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: October 8, 2019
    Assignee: MARINE BIOMEDICAL RESEARCH INSTITUTE OF QINGDAO CO., LTD.
    Inventors: Wenbao Li, Tianwen Sun, Shixiao Wang, Jianchun Zhao, Bing Cai, Huashi Guan
  • Publication number: 20180140600
    Abstract: Provided are a deuterium-substituted dehydrophenylahistin-like compound, preparation method thereof and use in a preparation of antitumor drugs. The deuterium-substituted dehydrophenylahistin-like compound has a structure of general formula (I), and a synthesis method thereof comprises: firstly conducting a condensation reaction of diacetyldiketopiperazine and an aldehyde intermediate a or a deuterated aldehyde compound b to form a heterocyclic compound c or a deuterium-containing heterocyclic compound d, which is then subjected to a condensation reaction with benzaldehyde and a deuterium-substituted benzaldehyde-like compound to form the deuterium-substituted dehydrophenylahistin-like compound. Also provided are a highly effective deuterated aldehyde intermediate with a high deuterium substitution rate and a deuterium-containing heterocycle intermediate, and a synthesis method thereof.
    Type: Application
    Filed: May 27, 2016
    Publication date: May 24, 2018
    Inventors: Wenbao LI, Tianwen SUN, Shixiao WANG, Jianchun ZHAO, Bing CAI, Huashi GUAN